Post-Market Study of the Ellipse PRECICE Intramedullary Limb Lengthening System — PINS

Limb Length Discrepancy Clinical Trial

Official title:
A Post-Market Prospective Evaluation of the Performance and Safety of the Ellipse PRECICE Intramedullary Limb Lengthening System

Status Active, not recruiting

Clinical Trial Summary

The purpose of this study is to obtain post market performance and safety data of the Ellipse PRECICE Intramedullary Limb Lengthening System for subjects undergoing unilateral limb lengthening.

Clinical Trial Description

Subject data will be reviewed at the following visits:

- Preoperative

- Operative

- Every 7 to 14 days through Distraction Phase

- Every 4 to 6 weeks through Consolidation Phase

- 6-Month Post-Consolidation

- 12-Month Post-Consolidation

- 18-Month Post-Consolidation

- 24-Month Post-Consolidation ;

Study Design

Related Conditions & MeSH terms

Limb Length Discrepancy

Clinical Trial Details

NCT number	NCT01601301
Study type	Interventional
Source	Ellipse Technologies, Inc.
Contact
Status	Active, not recruiting
Phase	N/A
Start date	July 2012
Completion date	June 2018

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT06173557` - Intraoperative Measurement Technique
Completed	`NCT01738113` - Open Versus Closed Kinetic Chain Exercises in Tibial Distraction Osteogenesis by Ilizarov's METHOD	Phase 2
Recruiting	`NCT04367753` - Predictive Factors for the Results of Epiphysiodesis in Limb Length Discrepancy
Active, not recruiting	`NCT05365594` - Biomechanical Analysis of CAM Boot and EVENUp Lift	N/A